Results 131 to 140 of about 45,597 (264)
Biochemical basis of endogenous bioluminescent springtail Lobella sauteri (Collembola)
Manabu Bessho-Uehara +4 more
doaj +1 more source
A practical guideline for in vivo bioluminescence imaging. [PDF]
Lee H, Chae JS, Park HW.
europepmc +1 more source
Programmable 3D Microfluidics Reveals Motility‐Driven Antibiotic Resistance Evolution in Gradients
Using a programmable microfluidic platform, this study shows that bacterial motility is crucial for resistance development in heterogeneous antibiotic landscapes. Motile Escherichia coli randomly migrates along antibiotic gradients, and sufficient movement is required for resistance to emerge.
Xiaobo Li +8 more
wiley +1 more source
Lineage-specific expansion of luciferin-binding protein genes associated with the evolution of bioluminescence in Scleralcyonacea. [PDF]
Zhang C +8 more
europepmc +1 more source
ABSTRACT Background Cell therapy, particularly those utilizing mesenchymal stem/stromal cells (MSCs), is gaining traction as a therapeutic option for regenerative treatment in patients with limited therapeutic options. Although the safety of MSC‐based interventions is well established, uncertainties remain regarding how genetic abnormalities and ...
Marzena Zychowicz +12 more
wiley +1 more source
A novel bone and cancer cells co-culture methodology to model breast cancer metastasis to bone ex vivo. [PDF]
Romero-Moreno RJ +5 more
europepmc +1 more source
Abstract Background and Purpose Site‐specific antibody modification is a useful chemical strategy to elaborate antibody therapeutic function. Conventional lysine‐ or cysteine‐based conjugation methods generate heterogeneous products, while protein engineering approaches are resource‐intensive.
Karolina Krygier +2 more
wiley +1 more source
Effects of surfactants on luminescence intensity and duration of the minimal luciferase picALuc. [PDF]
Ohmuro-Matsuyama Y +8 more
europepmc +1 more source
The c‐Src inhibitor eCF506 diminishes opioid tolerance and reduces β‐arrestin2 recruitment
Morphine activation of μ receptors causes tolerance through c‐Src activation and β‐arrestin2 recruitment. c‐Src inhibition or degradation reduces β‐arrestin2 recruitment, μ receptor endocytosis, while causing receptor upregulation, all likely contributing to reduced morphine tolerance.
Samuel Singleton +6 more
wiley +1 more source

